&Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
&Partners's FTXH Position: Q3 2026 in Review
&Partners opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 340,063 shares worth $14.1M. The stake represents 0.05% of the portfolio and ranks #320 among its holdings.
70 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.
- &Partners held 340,063 shares of First Trust Nasdaq Pharmaceuticals ETF worth $14.1M as of Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF was a new &Partners position in Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF made up 0.05% of &Partners's portfolio in Q3 2026, its #320 holding.
- 70 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.
Based on &Partners's 13F filing for Q3 2026, filed 16 Nov 2026.